Silver Investment Partners Acquires Stake in Crystal GmbH from SHS

Silver Investment Partners Acquires Crystal Laser Systems GmbH (CryLaS)

March 11, 2021

Manufacturing

Silver Investment Partners (SIP) has acquired Crystal Laser Systems GmbH (CryLaS) from healthcare investor SHS Gesellschaft für Beteiligungsmanagement mbH. CryLaS, a Berlin-based manufacturer of deep‑UV pulsed and CW laser systems serving the semiconductor, biotech and healthcare markets with around 50 employees, will work with SIP to expand product development, production capacity and market reach.

SK Capital Partners and Edgewater Capital Partners Acquire Saint-Gobain's Crystals Business (rebranded Luxium Solutions)

September 1, 2022

Manufacturing

Funds advised by SK Capital Partners and Edgewater Capital Partners completed the acquisition of Saint-Gobain's scintillation and photonic crystals business and will rebrand the carve‑out as Luxium Solutions. The business, headquartered in Hiram, Ohio with global facilities in the United States, France and India, supplies scintillation crystals and sapphire/garnet substrates for medical imaging, semiconductor and defense end markets.

Goldman Sachs Alternatives Takes Majority Stake in Crystal Group

May 6, 2024

Wealth Management

The Private Equity business at Goldman Sachs Alternatives has agreed to become the majority shareholder in French wealth manager Crystal, alongside Crystal's management team led by Bruno Narchal and Jean-Maximilien Vancayezeele; Seven2 will remain a c.25% shareholder. Crystal, founded in 1992, manages around €22 billion AUM (pro forma for recent acquisitions) and said the investment will support growth in France and internationally, including significant investments in digital and AI. The transaction is subject to regulatory and antitrust approvals.

SHS Capital and ING Corporate Investments Acquire Majority Stake in CAM Bioceramics

July 7, 2023

Medical Devices

German healthcare specialist investor SHS Capital, together with ING Corporate Investments and several co-investors, acquired a majority stake in CAM Bioceramics B.V., a Leiden-based contract development and manufacturing organization (CDMO) for orthobiologic calcium phosphate solutions. Existing owners rolled over a significant stake and management remains in place; the transaction aims to strengthen the business and accelerate investment in people, capabilities and customer partnerships to drive growth.

SHS Invests in Blue Ocean Spine GmbH

January 12, 2021

Medical Devices

SHS Gesellschaft für Beteiligungsmanagement (SHS) is the lead investor in Blue Ocean Spine GmbH, a Tuttlingen, Germany-based developer of functional spinal implants that uses additive manufacturing. The investment will support product development, manufacturing scale-up and regulatory activities as Blue Ocean Spine advances next-generation expandable and anchor-equipped cage implants and targets future U.S. FDA approval.

SHS Capital Invests €18M in MESI Medical

June 22, 2023

Medical Devices

Tübingen-based healthcare investor SHS (SHS Gesellschaft für Beteiligungsmanagement mbH) has invested €18 million in MESI, a Slovenian medtech company that develops the MESI mTABLET digital diagnostic platform. The growth capital will be used to expand MESI’s sales organization and product portfolio — including AI-powered predictive applications — to accelerate adoption across primary care, assisted care and other healthcare settings.